Search Within

Andrea Cercek Hanjis

Formats
  1. Meeting Abstract (161)
  2. Journal Article (151)
  3. Editorial (11)
  4. Review (9)
  5. Correspondence (6)
  6. Miscellaneous (6)
  7. Research Letter (3)
  8. Book Section (2)
  9. Guidelines (2)
Groups
  1. Department of Medicine (351)
  2. Gastrointestinal Oncology Service (351)
  3. Solid Tumor Oncology Division (351)
  4. Survivorship Research (351)
  5. Center for Pancreatic Cancer Research (235)
  6. Surgery (227)

More Groups

People
  1. Leonard Saltz (124)
  2. Nancy Kemeny (104)
  3. Martin Weiser (96)
  4. Rona Yaeger (93)
  5. Julio Garcia Aguilar (87)
  6. Michael D'Angelica (81)

More People

Years
  1. 2025 (20)
  2. 2024 (48)
  3. 2023 (49)
  4. 2022 (37)
  5. 2021 (33)
  6. 2020 (24)

More Years

Publications
  1. Journal of Clinical Oncology (112)
  2. Annals of Surgical Oncology (39)
  3. Annals of Oncology (20)
  4. Clinical Cancer Research (15)
  5. International Journal of Radiation Oncology, Biology, Physics (10)
  6. Clinical Colorectal Cancer (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (120)
  2. Springer (53)
  3. Elsevier Inc. (33)
  4. Oxford University Press (29)
  5. American Association for Cancer Research (23)
  6. Wiley Blackwell (15)

More Publishers

Results (351)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequency of minimal residual disease as measured by ctDNA in mismatch repair deficient tumors following curative resection
    Meeting Abstract

    Janjigian, Y.; Lumish, M.; Jayakumaran, G.; Fox, M.; Sabwa, S.; Cercek, A.; Stadler, Z.; Ku, G.; Segal, N.; Won, E.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • MOUNTAINEER: Open-label, phase 2 study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress)
    Meeting Abstract

    Siena, S.; Elez, E.; Peeters, M.; André, T.; Van den Eynde, M.; Ng, K.; Cercek, A.; Fountzilas, C.; Sanchez, F.; Hubbard, J.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Factors associated with local tumor control and complications after thermal ablation of colorectal cancer liver metastases: A 15-year retrospective cohort study
    Journal Article

    Kurilova, I.; Bendet, A.; Petre, E. N.; Boas, F. E.; Kaye, E.; Gonen, M.; Covey, A.; Brody, L. A.; Brown, K. T.; Kemeny, N. E.; more...
    Clinical Colorectal Cancer (2021)

    Fulltext@MSK | Save
  • Intrahepatic cholangiocarcinoma with lymph node metastasis: Treatment-related outcomes and the role of tumor genomics in patient selection
    Journal Article

    Jolissaint, J. S.; Soares, K. C.; Seier, K. P.; Kundra, R.; Gönen, M.; Shin, P. J.; Boerner, T.; Sigel, C.; Madupuri, R.; Vakiani, E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Impact of primary tumor laterality on adjuvant hepatic artery infusion pump chemotherapy in resected colon cancer liver metastases: Analysis of 487 patients
    Journal Article

    Gholami, S.; Stewart, S.; Kemeny, N.; Gönen, M.; Groot Koerkamp, B.; Cercek, A.; Kingham, P.; Balachandran, V.; Allen, P.; DeMatteo, R.; more...
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Radiation segmentectomy of hepatic metastases with Y-90 glass microspheres
    Journal Article

    Kurilova, I.; Bendet, A.; Fung, E. K.; Petre, E. N.; Humm, J. L.; Boas, F. E.; Crane, C. H.; Kemeny, N.; Kingham, T. P.; Cercek, A.; more...
    Abdominal Radiology (2021)

    Fulltext@MSK | Save
  • MOUNTAINEER: Open-label, phase II study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress)
    Meeting Abstract

    Strickler, J. H.; Ng, K.; Cercek, A.; Fountzilas, C.; Sanchez, F. A.; Hubbard, J. M.; Wu, C.; Siena, S.; Tabernero, J.; Van Cutsem, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • PULSE: A randomized phase II open label study of panitumumab rechallenge versus standard therapy after progression on anti-EGFR therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Strickler, J. H.; Ou, F. S.; Bekaii-Saab, T. S.; Parseghian, C. M.; Cercek, A.; Ng, K.; Sanchez, F. A.; Bruggeman, S.; Larson, J. J.; Finley, G. G.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of early-onset versus average-onset esophagogastric cancer
    Meeting Abstract

    Lumish, M. A.; Sabwa, S.; Maron, S. B.; Ku, G. Y.; Ilson, D. H.; Won, E.; Li, J.; Joshi, S. S.; Gu, P.; Strong, V. E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Early liver metastases after “failure” of adjuvant chemotherapy for stage III colorectal cancer: Is there a role for additional adjuvant therapy?
    Journal Article

    Boerner, T.; Zambirinis, C.; Gagnière, J.; Chou, J. F.; Gonen, M.; Kemeny, N. E.; Cercek, A.; Connell, L. C.; Kingham, T. P.; Allen, P. J.; more...
    HPB (2021)

    Fulltext@MSK | Save